164 related articles for article (PubMed ID: 19779260)
1. [Dosimetric verification and clinical efficacy of intensity modulated radiotherapy in nasopharyngeal carcinoma].
Zhang Y; Lin J; Zhou W; Tang J; Liao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 34(9):879-85. PubMed ID: 19779260
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
3. Technical and dosimetric considerations in multi-isocenter intensity modulated radiotherapy for nasopharyngeal carcinoma with small multileaf collimator.
Xiance J; Shixiu W; Jianyi Y; Jinling Y
Med Dosim; 2009; 34(1):9-15. PubMed ID: 19181249
[TBL] [Abstract][Full Text] [Related]
4. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?
Lai SZ; Li WF; Chen L; Luo W; Chen YY; Liu LZ; Sun Y; Lin AH; Liu MZ; Ma J
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):661-8. PubMed ID: 20643517
[TBL] [Abstract][Full Text] [Related]
5. Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients.
Hsin CH; Chen TH; Young YH; Liu WS
Otolaryngol Head Neck Surg; 2010 Nov; 143(5):662-8. PubMed ID: 20974336
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric difference amongst 3 techniques: TomoTherapy, sliding-window intensity-modulated radiotherapy (IMRT), and RapidArc radiotherapy in the treatment of late-stage nasopharyngeal carcinoma (NPC).
Lee FK; Yip CW; Cheung FC; Leung AK; Chau RM; Ngan RK
Med Dosim; 2014; 39(1):44-9. PubMed ID: 24321222
[TBL] [Abstract][Full Text] [Related]
7. A treatment planning analysis of inverse-planned and forward-planned intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Poon I; Xia P; Weinberg V; Sultanem K; Akazawa C; Akazawa P; Verhey L; Quivey JM; Lee N
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1625-33. PubMed ID: 18035216
[TBL] [Abstract][Full Text] [Related]
8. Set-up errors analyses in IMRT treatments for nasopharyngeal carcinoma to evaluate time trends, PTV and PRV margins.
Mongioj V; Orlandi E; Palazzi M; Deponti E; Marzia F; Stucchi C; Sangalli C; Fallai C; Zonca G; Olmi P; Pignoli E
Acta Oncol; 2011 Jan; 50(1):61-71. PubMed ID: 20735283
[TBL] [Abstract][Full Text] [Related]
9. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques.
Fang FM; Tsai WL; Chen HC; Hsu HC; Hsiung CY; Chien CY; Ko SF
Cancer; 2007 Jan; 109(2):313-21. PubMed ID: 17154159
[TBL] [Abstract][Full Text] [Related]
11. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary application of kilo-volt cone-beam computed tomography to intensity-modulated radiotherapy of nasopharyngeal carcinoma].
Wang J; Xu F; Bai S; Zhang H; Zhong RM; Li Y; Li XY
Ai Zheng; 2008 Jul; 27(7):761-5. PubMed ID: 18606073
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
Tham IW; Lin S; Pan J; Han L; Lu JJ; Wee J
Am J Clin Oncol; 2010 Jun; 33(3):294-9. PubMed ID: 20395788
[TBL] [Abstract][Full Text] [Related]
14. Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study.
Verbakel WF; Cuijpers JP; Hoffmans D; Bieker M; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):252-9. PubMed ID: 19362244
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal carcinoma in children: comparison of conventional and intensity-modulated radiotherapy.
Laskar S; Bahl G; Muckaden M; Pai SK; Gupta T; Banavali S; Arora B; Sharma D; Kurkure PA; Ramadwar M; Viswanathan S; Rangarajan V; Qureshi S; Deshpande DD; Shrivastava SK; Dinshaw KA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):728-36. PubMed ID: 18374512
[TBL] [Abstract][Full Text] [Related]
17. [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
Lu TX; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Zeng ZF; Huang SM; Lin CG; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):386-9. PubMed ID: 12921573
[TBL] [Abstract][Full Text] [Related]
18. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
19. [Dosimetric comparison of intensity-modulated arc radiotherapy and fixed beam dynamic intensity-modulated radiation therapy in nasopharyngeal carcinoma].
Yang Z; Bin S; Lei M; Liu G; Zhang Z; Lu Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 May; 37(5):474-80. PubMed ID: 22659659
[TBL] [Abstract][Full Text] [Related]
20. Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.
Chen AM; Li BQ; Farwell DG; Marsano J; Vijayakumar S; Purdy JA
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):756-62. PubMed ID: 20421143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]